Skip to main content

BAKER BROS. ADVISORS LP

Position in TCRX — TScan Therapeutics, Inc.

CIK 1263508 NEW YORK, NY

Position in TCRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,812,639
+$27,847 QoQ
Shares Held
2,784,792
0.0% QoQ
Ownership
4.26%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. TCRX ranks #72 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TCRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,812,639 2,784,792
2025-12-31 $2,784,792 2,784,792
2025-09-30 $5,068,321 2,784,792
2025-06-30 $4,037,948 2,784,792
2025-03-31 $3,843,012 2,784,792
2024-12-31 $8,465,767 2,784,792
2024-09-30 $13,868,264 2,784,792
2024-06-30 $16,291,033 2,784,792
2024-03-31 $22,111,248 2,784,792
2023-12-31 $16,235,337 2,784,792
2023-09-30 $7,129,067 2,784,792
2023-06-30 $6,961,980 2,784,792
2023-03-31 $5,848,063 2,784,792
2022-12-31 $4,316,427 2,784,792
2022-09-30 $8,493,615 2,784,792
2022-06-30 $8,758,170 2,784,792
2022-03-31 $3,990,000 1,425,000
2021-12-31 $6,412,500 1,425,000
2021-09-30 $11,884,500 1,425,000